Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Filippo de Marinis"'
Autor:
Filippo de Marinis, Francesca Porta, Elena Guerini-Rocco, Carmine Valenza, Giuseppe Curigliano, Chiara Catania, Alessandra Rappa, Massimo Barberis, Giuseppe Viale
Publikováno v:
Current Oncology, Vol 28, Iss 292, Pp 3384-3392 (2021)
Current Oncology
Current Oncology
We present a case of a woman with epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma who received gefitinib for 2 years and obtained a partial response. The patient then developed liver metastasis and a breast lesion, displaying high
Autor:
Ilaria Attili, Filippo de Marinis, Emilio Bria, Domenico Galetta, Alain Gelibter, Maria Lucia Reale, Diana Giannarelli, Valeria Stati, Pamela Pizzutilo, Alessio Stefani, Silvia Novello, Antonio Passaro, Simona Carnio, Emanuele Vita
Publikováno v:
Cancers, Vol 13, Iss 2935, p 2935 (2021)
Cancers
Volume 13
Issue 12
Cancers
Volume 13
Issue 12
Background: Pembrolizumab is approved in monotherapy for the first-line (1L) of advanced or metastatic NSCLC patients with high PD-L1 (≥50%). Despite a proportion of patients achieve long-term survival, about one-third of patients experience detrim
Autor:
Filippo de Marinis, Juliana Guarize, Francesco Petrella, Cristiano Rampinelli, Gaia Piperno, Davide Radice, Lorenzo Spaggiari
Publikováno v:
Cancers, Vol 13, Iss 228, p 228 (2021)
Cancers
Volume 13
Issue 2
Cancers
Volume 13
Issue 2
Background: the aim of this paper is to quantify multidisciplinary team meeting (MDT) impact on the decisional clinical pathway of thoracic cancer patients, assessing the modification rate of the initial out-patient evaluation. Methods: the impact of
Autor:
Candida Bonelli, Luca Giovanni Ceresoli, Marina Chiara Garassino, Filippo de Marinis, Francesco Grossi, Paolo Andrea Zucali, Nicola Normanno, Alessia Ciarrocchi, Hector Soto Parra, Maria Pagano, Federico Cappuzzo, Paolo Pedrazzoli, Marcello Tiseo, Federica Torricelli, F. Zanelli, Carmine Pinto, R. Gnoni, Federica Grosso, Giulia Pasello
Publikováno v:
Cancers
Cancers, Vol 12, Iss 2948, p 2948 (2020)
Volume 12
Issue 10
Cancers, Vol 12, Iss 2948, p 2948 (2020)
Volume 12
Issue 10
Purpose: Malignant pleural mesothelioma (MPM) is an aggressive cancer. Data are not available in prospective trials on correlations between genetic alterations and outcomes of therapies. In this study, we assessed the genetic profile of MPM patients
Autor:
Filippo de Marinis, Alessandra Sacco, Rita Chiari, Giovanna Finocchiaro, Nicola Normanno, Federico Cappuzzo, Laura Giannetta, Ciro Battiloro, Raffaella Pasquale, Alessandro Morabito, Libero Ciuffreda, Marcello Tiseo, Maria Carmela Piccirillo, Roberta Buosi, Paolo Bidoli, Luisa Foltran, Riziero Esposito Abate, Gianpiero Fasola, G. Romano, Antonio Frassoldati
Publikováno v:
Cancers
Volume 11
Issue 10
Cancers, Vol 11, Iss 10, p 1431 (2019)
Volume 11
Issue 10
Cancers, Vol 11, Iss 10, p 1431 (2019)
The ICARUS trial is a phase II, open label, multicenter, single arm study conducted to investigate the efficacy, safety, and tolerability of a rechallenge treatment with the first-generation tyrosine kinase inhibitor (TKI) gefitinib in advanced non-s
Autor:
Camillo Porta, Stefano Fogli, Angela Michelucci, Iacopo Petrini, Giuliana Restante, Filippo de Marinis, Romano Danesi, Antonio Chella, Marzia Del Re, Stefania Crucitta, Giulia Gianfilippo, Antonio Passaro
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 16, p 3951 (2019)
Liquid biopsy has emerged as an alternative source of nucleic acids for the management of Epidermal Growth Factor Receptor (EGFR)-mutant non-Small Cell Lung Cancer (NSCLC). The use of circulating cell-free DNA (cfDNA) has been recently introduced in